SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GENZYME - THE KING OF THE BIOTECHS -- Ignore unavailable to you. Want to Upgrade?

To: Vector1 who wrote (331)7/30/1998 7:21:00 PM
From: Myron Z.  Read Replies (1) | Respond to of 410
 
Tired of GENZ? Try following QMDC (Quardamed) as a nice short term / day trading stock or for the longer term.



To: Vector1 who wrote (331)7/31/1998 11:57:00 AM
From: H. Bradley Toland, Jr.  Read Replies (1) | Respond to of 410
 
Vector1

The final agreement is not signed, but will be shortly with BioMarin. My source is GENZ's June 20th news release.

Another potential blockbuster is Pompe's. In an agreemnet with Farming, GENZ will joint venture with them. Great fit with GENZ because of GENZ's reimbursement expertise and marketing expertise. This was new release July 14th.

Both of these agreements should be inked by end of Aug.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News